195 related articles for article (PubMed ID: 28264652)
1. Insight into SNPs and epitopes of E protein of newly emerged genotype-I isolates of JEV from Midnapur, West Bengal, India.
Banerjee S; Sen Gupta PS; Bandyopadhyay AK
BMC Immunol; 2017 Mar; 18(1):13. PubMed ID: 28264652
[TBL] [Abstract][Full Text] [Related]
2. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
[TBL] [Abstract][Full Text] [Related]
3. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein.
Chiou SS; Fan YC; Crill WD; Chang RY; Chang GJ
J Gen Virol; 2012 Jun; 93(Pt 6):1185-1192. PubMed ID: 22337639
[TBL] [Abstract][Full Text] [Related]
5. Molecular evidence for the occurrence of Japanese encephalitis virus genotype I and III infection associated with acute encephalitis in patients of West Bengal, India, 2010.
Sarkar A; Taraphdar D; Mukhopadhyay SK; Chakrabarti S; Chatterjee S
Virol J; 2012 Nov; 9():271. PubMed ID: 23153306
[TBL] [Abstract][Full Text] [Related]
6. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
7. Complete genome sequence of two genotype III Japanese encephalitis virus isolates from West Bengal, India.
Taraphdar D; Chatterjee S
Indian J Med Res; 2015 Jul; 142(1):72-8. PubMed ID: 26261169
[TBL] [Abstract][Full Text] [Related]
8. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
[TBL] [Abstract][Full Text] [Related]
9. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
[TBL] [Abstract][Full Text] [Related]
10. Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody.
Deng WL; Guan CY; Liu K; Zhang XM; Feng XL; Zhou B; Su XD; Chen PY
Virus Res; 2014 Jan; 179():133-9. PubMed ID: 24184444
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
Nath B; Gupta A; Khan SA; Kumar S
Microb Pathog; 2017 Oct; 111():187-192. PubMed ID: 28867626
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
Yu Y
Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
[TBL] [Abstract][Full Text] [Related]
15. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the research of phenotype and genotype of Japanese encephalitis virus in China].
Chen N; Yu YX
Bing Du Xue Bao; 2013 Jun; 29(4):457-64. PubMed ID: 23895014
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964-2011: genotype replacement.
Do LP; Bui TM; Hasebe F; Morita K; Phan NT
Virol J; 2015 Apr; 12():51. PubMed ID: 25889499
[TBL] [Abstract][Full Text] [Related]
18. Structural and molecular analyses of functional epitopes and escape mutants in Japanese encephalitis virus envelope protein domain III.
Roy U
Immunol Res; 2020 Apr; 68(2):81-89. PubMed ID: 32445181
[TBL] [Abstract][Full Text] [Related]
19. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
20. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
